Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUKE: Dornase alfa and Urokinase for Pediatric Pleural Empyema
NCT00502632Phase 3Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Oct 2007
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dornase alfa in pleural empyema, sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Duration of hospital stay. Status: unknown.
02
Drugs
dornase alfa
03
Conditions
pleural empyema
Beyond the preview
Go deeper on NCT00502632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502632.